Biolinerx Ltd ADR (BLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,730 | -30,707 | -12,162 | -24,951 | -19,220 |
| Depreciation Amortization | 678 | 457 | 259 | 654 | 467 |
| Other Working Capital | 493 | -675 | 273 | 1,238 | -25 |
| Other Operating Activity | 17,960 | 13,227 | 3,614 | -3,181 | -1,779 |
| Operating Cash Flow | $-27,599 | $-17,698 | $-8,016 | $-26,240 | $-20,557 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,118 | 17,994 | 6,771 | 4,322 | 232 |
| PPE Investments | -100 | -99 | -32 | -131 | -74 |
| Purchase Sale Intangibles | -179 | -153 | -97 | -185 | -14 |
| Other Investing Activity | -179 | -153 | -97 | -185 | -14 |
| Investing Cash Flow | $21,839 | $17,742 | $6,642 | $4,006 | $144 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 9,126 | 9,682 |
| Debt Repayment | -802 | N/A | N/A | -2,832 | -2,832 |
| Common Stock Issued | 4,441 | N/A | N/A | 14,364 | 14,361 |
| Other Financing Activity | -323 | -183 | -49 | -220 | -126 |
| Financing Cash Flow | $3,316 | $-183 | $-49 | $20,438 | $21,085 |
| Exchange Rate Effect | -416 | -344 | -98 | -607 | -557 |
| Beginning Cash Position | 10,587 | 10,587 | 10,587 | 12,990 | 12,990 |
| End Cash Position | 7,727 | 10,104 | 9,066 | 10,587 | 13,105 |
| Net Cash Flow | $-2,860 | $-483 | $-1,521 | $-2,403 | $115 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,599 | -17,698 | -8,016 | -26,240 | -20,557 |
| Capital Expenditure | -100 | -99 | -32 | -131 | -74 |
| Free Cash Flow | -27,699 | -17,797 | -8,048 | -26,371 | -20,631 |